Initiator Pharma A/S, a clinical-stage pharma company developing innovative drugs targeting key unmet medical needs within the central and peripheral nervous system. Initiator Pharma is listed on First North Stockholm, Sweden (INIT).
Initiator Pharma’s pipeline consists of three clinical programs – the clinical programs IP2018 and pudafensine for treatment of erectile dysfunction of psychogenic and organic origin, respectively, and a neuropathic pain program based on pudafensine.
Furthermore, Initiator Pharma has recent announce that the drug candidates, pudafensine and IP2018, have shown significant efficacy in preclinical models for Female Sexual Dysfunction (FSD).
Company Details
- Employees
- 8
- Founded
- -
- Address
- Ole Maaløes Vej, Copenhagen,capital Region Of Denmark 2200,denmark
- Phone
- +45 6126 0035
- ce****@****rma.com
- Industry
- Biotechnology
- Website
- initiatorpharma.com
- Keywords
- Engineer jobs.
- HQ
- Copenhagen, Capital Region of Denmark
Initiator Pharma Questions
Initiator Pharma's helpline number is +45 6126 0035
Initiator Pharma's website is initiatorpharma.com
Initiator Pharma's LinkedIn profile is https://dk.linkedin.com/company/initiatorpharma.com
Initiator Pharma has
8 employees.
View email and phone details for 8
employees at Initiator Pharma.
Initiator Pharma's industry is
Biotechnology
Initiator Pharma's top competitors are
Teitur Trophics,
Boost Pharma,
Zerion Pharma,
Macure Pharma,
Draupnir Bio,
Acesion Pharma,
Ousia Pharma,
Avilex Pharma Aps,
Contera Pharma,
Nmd Pharma A/s.
Initiator Pharma's support email address is ceo@initiatorpharma.com
Initiator Pharma's categories are Biotechnology
Initiator Pharma's founding year is 2016
